Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma

被引:14
作者
Fujii, Yoichi [1 ]
Ikeda, Masaomi [1 ]
Kurosawa, Kazuhiro [1 ]
Tabata, Mariko [1 ]
Kamigaito, Takayuki [1 ]
Hosoda, Chihiro [1 ]
Okaneya, Toshikazu [1 ]
机构
[1] Toranomon Gen Hosp, Dept Urol, Minato Ku, Tokyo 1058470, Japan
关键词
Renal cell carcinoma; Late recurrence; Predictive factor; Surgery; Nephrectomy; PROGNOSTIC FACTORS; INTERFERON-ALPHA; NEPHRECTOMY; GUIDELINES; SURVIVAL; CANCER; SURVEILLANCE; METASTASIS;
D O I
10.1007/s10147-014-0775-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To evaluate the clinicopathological features and identify predictive factors in patients with early and late recurrence following initial surgery for localized renal cell carcinoma. Methods From April 1988 to January 2013, 486 patients without metastases at the initial diagnosis underwent either radical nephrectomy or partial nephrectomy and were followed up thereafter. Patients were divided into 3 groups; no recurrence, early recurrence (recurrence within 5 years), and late recurrence (recurrence after 5 years). Cancer-specific survival after recurrence was analyzed by using the Kaplan-Meier method. Multivariate logistic regression analysis was applied to define clinical and pathological factors correlated to early and late recurrence following surgery. Results Seventy-seven (15.8 %) and 18 (3.7 %) patients developed early and late recurrence, respectively. In multivariate logistic regression analysis, positive symptoms at diagnosis, >= pT2, positive lymphovascular invasion, and grade 3 were independent predictive factors for early recurrence. Age at surgery and >= pT2 were significantly correlated to late recurrence. The 5-year cancer-specific survival rate after recurrence was 72.4 and 52.9 % in the late and the early recurrence groups, respectively (P = 0.044). Conclusions The risk factors for clinical recurrence differed according to the time that had elapsed between initial surgery and the first metastasis in patients with localized renal cell carcinoma. Our study showed age at initial surgery and the pT stage were independent predictive factors for late recurrence. Further investigation of a larger number of patients is required to predict which patients may develop recurrence in the future and to choose appropriate treatment.
引用
收藏
页码:802 / 807
页数:6
相关论文
共 28 条
  • [1] Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell Carcinoma
    Adamy, Ari
    Chong, Kian Tai
    Chade, Daher
    Costaras, James
    Russo, Grace
    Kaag, Matthew G.
    Bernstein, Melanie
    Motzer, Robert J.
    Russo, Paul
    [J]. JOURNAL OF UROLOGY, 2011, 185 (02) : 433 - 438
  • [2] Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun, S
    Pantel, K
    Muller, P
    Janni, W
    Hepp, F
    Kentenich, CRM
    Gastroph, S
    Wischnik, A
    Dimpfl, T
    Kindermann, G
    Riethmuller, G
    Schlimok, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) : 525 - 533
  • [3] Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)
    Brookman-May, Sabine
    May, Matthias
    Shariat, Shahrokh F.
    Xylinas, Evanguelos
    Stief, Christian
    Zigeuner, Richard
    Chromecki, Thomas
    Burger, Maximilian
    Wieland, Wolf F.
    Cindolo, Luca
    Schips, Luigi
    De Cobelli, Ottavio
    Rocco, Bernardo
    De Nunzio, Cosimo
    Feciche, Bogdan
    Truss, Michael
    Gilfrich, Christian
    Pahernik, Sascha
    Hohenfellner, Markus
    Zastrow, Stefan
    Wirth, Manfred P.
    Novara, Giacomo
    Carini, Marco
    Minervini, Andrea
    Simeone, Claudio
    Antonelli, Alessandro
    Mirone, Vincenzo
    Longo, Nicola
    Simonato, Alchiede
    Carmignani, Giorgio
    Ficarra, Vincenzo
    [J]. EUROPEAN UROLOGY, 2013, 64 (03) : 472 - 477
  • [4] The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
    Edge, Stephen B.
    Compton, Carolyn C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1471 - 1474
  • [5] Sorafenib in advanced clear-cell renal-cell carcinoma
    Escudier, Bernard
    Eisen, Tim
    Stadler, Walter M.
    Szczylik, Cezary
    Oudard, Stephane
    Siebels, Michael
    Negrier, Sylvie
    Chevreau, Christine
    Solska, Ewa
    Desai, Apurva A.
    Rolland, Frederic
    Demkow, Tomasz
    Hutson, Thomas E.
    Gore, Martin
    Freeman, Scott
    Schwartz, Brian
    Shan, Minghua
    Simantov, Ronit
    Bukowski, Ronald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 125 - 134
  • [6] Timeline - The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
    Fidler, IJ
    [J]. NATURE REVIEWS CANCER, 2003, 3 (06) : 453 - 458
  • [7] Gelb AB, 1997, CANCER-AM CANCER SOC, V80, P981
  • [8] Five-year survival after surgical treatment for kidney cancer - A population-based competing risk analysis
    Hollingsworth, John M.
    Miller, David C.
    Daignault, Stephanie
    Hollenbeck, Brent K.
    [J]. CANCER, 2007, 109 (09) : 1763 - 1768
  • [9] Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
    Hudes, Gary
    Carducci, Michael
    Tomczak, Piotr
    Dutcher, Janice
    Figlin, Robert
    Kapoor, Anil
    Staroslawska, Elzbieta
    Sosman, Jeffrey
    McDermott, David
    Bodrogi, Istvan
    Kovacevic, Zoran
    Lesovoy, Vladimir
    Schmidt-Wolf, Ingo G. H.
    Barbarash, Olga
    Gokmen, Erhan
    O'Toole, Timothy
    Lustgarten, Stephanie
    Moore, Laurence
    Motzer, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) : 2271 - 2281
  • [10] Systemic spread is an early step in breast cancer
    Huesemann, Yves
    Geigl, Jochen B.
    Schubert, Falk
    Musiani, Piero
    Meyer, Manfred
    Burghart, Elke
    Forni, Guido
    Eils, Roland
    Fehm, Tanja
    Riethmueller, Gert
    Klein, Christoph A.
    [J]. CANCER CELL, 2008, 13 (01) : 58 - 68